Verdicts genuinely change. Free email alert the moment FHCLX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Select Health Care Portfolio · Fidelity Select Portfolios
152 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 102% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 15.01% of portfolio weight is in non-compliant holdings, over the 5% threshold.
152 holdings, 72 matched (78% of weight). Portfolio as of 2026-05-31, filed 2026-07-24. Source: SEC Form N-PORT.
2.46% of this portfolio’s income is non-permissible — weighted across holdings, computed over 67% of portfolio weight (56 of 152 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
63.6% compliant 0.0% questionable 14.7% non-compliant 21.7% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY ELI LILLY and CO | COMPLIANT | 8.03% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| DHR DANAHER CORP | COMPLIANT | 6.89% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| JNJ JOHNSON and JOHNSON | COMPLIANT | 4.91% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 4.33% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 3.49% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 2.40% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GILD GILEAD SCIENCES INC | COMPLIANT | 2.21% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| BSX BOSTON SCIENTIFIC CORP | COMPLIANT | 2.17% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| ASND ASCENDIS PHARMA A/S | COMPLIANT | 2.17% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Fidelity Revere Street Trust | UNSCREENED | 2.17% | no in-house ratios for this holding |
| ABBV ABBVIE INC | COMPLIANT | 2.03% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| UCB.BR UCB SA | COMPLIANT | 2.03% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| TECH BIO TECHNE CORP | COMPLIANT | 1.70% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| MRK MERCK and CO INC | COMPLIANT | 1.60% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| ARGX ARGENX SE | COMPLIANT | 1.56% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 1.29% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| NUVALENT INC | UNSCREENED | 1.28% | no in-house ratios for this holding |
| NTRA NATERA INC | COMPLIANT | 1.27% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| BTSG BRIGHTSPRING HEALTH SERVICES INC | COMPLIANT | 1.23% | AAOIFI19.9% Usmani39.9% Dow Jones Islamic37.1% S&P Shariah45.1% MSCI Islamic39.6% MSCI Islamic M-Series45.1% FTSE Shariah36.6% |
| VTRS VIATRIS INC | NON_COMPLIANT | 1.20% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| MRNA MODERNA INC | NON_COMPLIANT | 1.18% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| COR CENCORA INC | COMPLIANT | 1.14% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| WST WEST PHARMACEUTICAL SVCS INC | COMPLIANT | 1.12% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 1.10% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| EW EDWARDS LIFESCIENCES CORP | COMPLIANT | 1.09% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| XENON PHARMACEUTICALS INC | UNSCREENED | 1.09% | no in-house ratios for this holding |
| CAI CARIS LIFE SCIENCES INC | COMPLIANT | 1.08% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| RPRX ROYALTY PHARMA PLC | NON_COMPLIANT | 1.08% | AAOIFI24.4% Usmani45.2% Dow Jones Islamic60.3% S&P Shariah67.3% MSCI Islamic45.2% MSCI Islamic M-Series67.3% FTSE Shariah45.2% |
| COGENT BIOSCIENCES INC | UNSCREENED | 1.06% | no in-house ratios for this holding |
| GH GUARDANT HEALTH INC | COMPLIANT | 1.03% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| VAXCYTE INC | UNSCREENED | 1.03% | no in-house ratios for this holding |
| VCYT VERACYTE INC | COMPLIANT | 1.03% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| RGEN REPLIGEN CORP | COMPLIANT | 0.99% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| SPYRE THERAPEUTICS INC | UNSCREENED | 0.97% | no in-house ratios for this holding |
| JAZZ JAZZ PHARMACEUTICALS PLC | COMPLIANT | 0.96% | AAOIFI31.0% Usmani39.7% Dow Jones Islamic44.2% S&P Shariah48.5% MSCI Islamic39.7% MSCI Islamic M-Series48.5% FTSE Shariah39.3% |
| REVOLUTION MEDICINES INC | UNSCREENED | 0.95% | no in-house ratios for this holding |
| LEGN LEGEND BIOTECH CORP | COMPLIANT | 0.94% | AAOIFI8.8% Usmani18.4% Dow Jones Islamic2.9% S&P Shariah2.3% MSCI Islamic18.4% MSCI Islamic M-Series2.3% FTSE Shariah18.4% |
| RO.SW ROCHE HOLDING AG | COMPLIANT | 0.93% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| PRVA PRIVIA HEALTH GROUP INC | NON_COMPLIANT | 0.93% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.6% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| INSMED INC | UNSCREENED | 0.92% | no in-house ratios for this holding |
| BRKR BRUKER CORP | COMPLIANT | 0.87% | AAOIFI18.9% Usmani30.1% Dow Jones Islamic25.7% S&P Shariah22.6% MSCI Islamic30.1% MSCI Islamic M-Series22.6% FTSE Shariah30.1% |
| ORUKA THERAPEUTICS INC | UNSCREENED | 0.84% | no in-house ratios for this holding |
| TXG 10X GENOMICS INC | COMPLIANT | 0.78% | AAOIFI1.0% Usmani7.6% Dow Jones Islamic3.2% S&P Shariah2.5% MSCI Islamic7.6% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| AXSM AXSOME THERAPEUTICS INC | COMPLIANT | 0.77% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| ENLIVEN THERAPEUTICS INC | UNSCREENED | 0.77% | no in-house ratios for this holding |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 0.75% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| CRINETICS PHARMACEUTICALS INC | UNSCREENED | 0.74% | no in-house ratios for this holding |
| KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | COMPLIANT | 0.71% | AAOIFI0.2% Usmani1.1% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic1.1% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| ALHC ALIGNMENT HEALTHCARE INC | COMPLIANT | 0.69% | AAOIFI11.6% Usmani25.3% Dow Jones Islamic10.0% S&P Shariah12.5% MSCI Islamic25.3% MSCI Islamic M-Series12.5% FTSE Shariah25.3% |
| LFST LIFESTANCE HEALTH GROUP INC | COMPLIANT | 0.66% | AAOIFI9.7% Usmani21.7% Dow Jones Islamic17.3% S&P Shariah18.0% MSCI Islamic21.7% MSCI Islamic M-Series18.0% FTSE Shariah12.5% |
| ROIVANT SCIENCES LTD | UNSCREENED | 0.66% | no in-house ratios for this holding |
| MINERALYS THERAPEUTICS INC | UNSCREENED | 0.64% | no in-house ratios for this holding |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 0.63% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| MDLN MEDLINE INC | NON_COMPLIANT | 0.63% | AAOIFI26.3% Usmani32.1% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic32.1% MSCI Islamic M-Seriespass FTSE Shariah32.0% |
| PRAXIS PRECISION MEDICINES INC. | UNSCREENED | 0.61% | no in-house ratios for this holding |
| ISRG INTUITIVE SURGICAL INC | COMPLIANT | 0.55% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| DISC MEDICINE INC | UNSCREENED | 0.54% | no in-house ratios for this holding |
| CG ONCOLOGY INC | UNSCREENED | 0.54% | no in-house ratios for this holding |
| HTFL HEARTFLOW INC | COMPLIANT | 0.54% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| BIIB BIOGEN INC | COMPLIANT | 0.51% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| TVTX TRAVERE THERAPEUTICS INC | COMPLIANT | 0.47% | AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4% |
| DIM.PA SARTORIUS STEDIM BIOTECH | COMPLIANT | 0.46% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| VIRIDIAN THERAPEUTICS INC | UNSCREENED | 0.46% | no in-house ratios for this holding |
| ONC BEONE MEDICINES LTD | COMPLIANT | 0.45% | AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7% |
| PHARVARIS BV | UNSCREENED | 0.42% | no in-house ratios for this holding |
| RELAY THERAPEUTICS INC | UNSCREENED | 0.41% | no in-house ratios for this holding |
| NEWAMSTERDAM PHARMA COMPANY NV | UNSCREENED | 0.40% | no in-house ratios for this holding |
| MIRM MIRUM PHARMACEUTICALS INC | COMPLIANT | 0.39% | AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8% |
| WAY WAYSTAR HOLDING CORP | NON_COMPLIANT | 0.37% | AAOIFI36.9% Usmani25.2% Dow Jones Islamic26.1% S&P Shariah— MSCI Islamic25.2% MSCI Islamic M-Series— FTSE Shariah25.0% |
| GPCR STRUCTURE THERAPEUTICS INC | NON_COMPLIANT | 0.37% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| SCHOLAR ROCK HOLDING CORP | UNSCREENED | 0.37% | no in-house ratios for this holding |
| IRTC IRHYTHM TECHNOLOGIES INC | COMPLIANT | 0.35% | AAOIFI17.9% Usmani66.5% Dow Jones Islamic17.8% S&P Shariah19.6% MSCI Islamic66.5% MSCI Islamic M-Series19.6% FTSE Shariah59.5% |
| AMYLYX PHARMACEUTICALS INC | UNSCREENED | 0.35% | no in-house ratios for this holding |
| ZBIO ZENAS BIOPHARMA INC | NON_COMPLIANT | 0.34% | AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2% |
| OLMA OLEMA PHARMACEUTICALS INC | NON_COMPLIANT | 0.34% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| STOK STOKE THERAPEUTICS INC | NON_COMPLIANT | 0.34% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| DIANTHUS THERAPEUTICS INC | UNSCREENED | 0.33% | no in-house ratios for this holding |
| KMTS KESTRA MEDICAL TECHNOLOGIES INC | NON_COMPLIANT | 0.33% | AAOIFI5.2% Usmani22.0% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic22.0% MSCI Islamic M-Seriesfail FTSE Shariah20.9% |
| MBX BIOSCIENCES INC | UNSCREENED | 0.33% | no in-house ratios for this holding |
| VERADERMICS INC | UNSCREENED | 0.31% | no in-house ratios for this holding |
| CTMX CYTOMX THERAPEUTICS INC | NON_COMPLIANT | 0.31% | AAOIFI0.7% Usmani1.5% Dow Jones Islamic1.3% S&P Shariah1.8% MSCI Islamic1.5% MSCI Islamic M-Series1.8% FTSE Shariah0.0% |
| VIKING THERAPEUTICS INC | UNSCREENED | 0.31% | no in-house ratios for this holding |
| CLEERLY INC | UNSCREENED | 0.27% | no in-house ratios for this holding |
| PODD INSULET CORP | COMPLIANT | 0.25% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| IMCR IMMUNOCORE HOLDINGS PLC | NON_COMPLIANT | 0.25% | AAOIFI24.8% Usmani42.8% Dow Jones Islamic29.4% S&P Shariah24.5% MSCI Islamic42.8% MSCI Islamic M-Series24.5% FTSE Shariah39.2% |
| TXG 10X GENOMICS INC | COMPLIANT | 0.24% | AAOIFI1.0% Usmani7.6% Dow Jones Islamic3.2% S&P Shariah2.5% MSCI Islamic7.6% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| TREVI THERAPEUTICS INC | UNSCREENED | 0.24% | no in-house ratios for this holding |
| SUMMIT THERAPEUTICS INC | UNSCREENED | 0.24% | no in-house ratios for this holding |
| JBIO JADE BIOSCIENCES INC | NON_COMPLIANT | 0.23% | AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| DMRA DAMORA THERAPEUTICS INC | NON_COMPLIANT | 0.22% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| GMRS GMR SOLUTIONS INC | NON_COMPLIANT | 0.21% | AAOIFI684.4% Usmani64.0% Dow Jones Islamic661.7% S&P Shariah661.7% MSCI Islamic62.7% MSCI Islamic M-Series661.7% FTSE Shariah59.5% |
| CANDID THERAPEUTICS | UNSCREENED | 0.20% | no in-house ratios for this holding |
| Fidelity Revere Street Trust | UNSCREENED | 0.19% | no in-house ratios for this holding |
| EDGEWISE THERAPEUTICS INC | UNSCREENED | 0.17% | no in-house ratios for this holding |
| MEDICAL MICROINSTRUMENTS INC | UNSCREENED | 0.17% | no in-house ratios for this holding |
| TYRA TYRA BIOSCIENCES INC | COMPLIANT | 0.16% | AAOIFI0.3% Usmani1.5% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.5% MSCI Islamic M-Series0.6% FTSE Shariah0.0% |
| ENDEAVOR BIOMEDICINES INC | UNSCREENED | 0.15% | no in-house ratios for this holding |
| KARDIUM INC/US | UNSCREENED | 0.14% | no in-house ratios for this holding |
| INSIGHTEC LTD | UNSCREENED | 0.14% | no in-house ratios for this holding |
| SI SHOULDER INNOVATIONS INC | COMPLIANT | 0.14% | AAOIFI3.6% Usmani9.8% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic9.8% MSCI Islamic M-Seriespass FTSE Shariah9.7% |
| OM OUTSET MEDICAL INC | NON_COMPLIANT | 0.13% | AAOIFI152.4% Usmani43.1% Dow Jones Islamic85.4% S&P Shariah66.1% MSCI Islamic42.4% MSCI Islamic M-Series66.1% FTSE Shariah40.3% |
| APOGEE THERAPEUTICS INC | UNSCREENED | 0.13% | no in-house ratios for this holding |
| UPB UPSTREAM BIO INC | NON_COMPLIANT | 0.12% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ALUMIS INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| ANNX ANNEXON INC | COMPLIANT | 0.11% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ALEDADE INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| FIRST TRACKS BIOTHERAPEUTICS INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| ELEMENT BIOSCIENCES INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| ALMAR BIOSCIENCES INC | UNSCREENED | 0.11% | no in-house ratios for this holding |
| CTNM CONTINEUM THERAPEUTICS INC | NON_COMPLIANT | 0.10% | AAOIFI1.0% Usmani2.6% Dow Jones Islamic2.5% S&P Shariah2.4% MSCI Islamic2.6% MSCI Islamic M-Series2.4% FTSE Shariah0.0% |
| PARABILIS MEDICINES INC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| CELLCENTRIC LTD | UNSCREENED | 0.10% | no in-house ratios for this holding |
| OCUL OCULAR THERAPEUTIX INC | NON_COMPLIANT | 0.08% | AAOIFI0.3% Usmani1.0% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic1.0% MSCI Islamic M-Series0.5% FTSE Shariah0.0% |
| KARDIUM INC/US | UNSCREENED | 0.08% | no in-house ratios for this holding |
| GALVANIZE THERAPEUTICS | UNSCREENED | 0.07% | no in-house ratios for this holding |
| MANUS BIO INC | UNSCREENED | 0.06% | no in-house ratios for this holding |
| PERCEPTIVE CAPITAL SOLUTIONS CORP | UNSCREENED | 0.06% | no in-house ratios for this holding |
| ELEMENT BIOSCIENCES INC | UNSCREENED | 0.05% | no in-house ratios for this holding |
| ELEMENT BIOSCIENCES INC | UNSCREENED | 0.05% | no in-house ratios for this holding |
| ZBIO ZENAS BIOPHARMA INC | NON_COMPLIANT | 0.05% | AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2% |
| GALVANIZE THERAPEUTICS | UNSCREENED | 0.05% | no in-house ratios for this holding |
| ASIMOV INC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| WUGEN INC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| HEAL THRIVE HOLDINGS LLC | UNSCREENED | 0.04% | no in-house ratios for this holding |
| DMED BIOPHARMACEUTICAL CO LTD | UNSCREENED | 0.04% | no in-house ratios for this holding |
| HEMAB THERAPEUTICS HOLDINGS INC | UNSCREENED | 0.03% | no in-house ratios for this holding |
| ALEDADE INC | UNSCREENED | 0.03% | no in-house ratios for this holding |
| KARDIUM INC/US | UNSCREENED | 0.03% | no in-house ratios for this holding |
| IMNM IMMUNOME INC | NON_COMPLIANT | 0.02% | AAOIFI0.2% Usmani0.8% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| GALVANIZE THERAPEUTICS | UNSCREENED | 0.02% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.02% | no in-house ratios for this holding |
| SALUDA MEDICAL INC | UNSCREENED | 0.02% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.01% | no in-house ratios for this holding |
| WUGEN INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| CYCLERION THERAPEUTICS INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.01% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.01% | no in-house ratios for this holding |
| INM INMED PHARMACEUTICALS INC | NON_COMPLIANT | 0.01% | AAOIFI6.0% Usmani13.9% Dow Jones Islamic12.8% S&P Shariah14.9% MSCI Islamic13.9% MSCI Islamic M-Series14.9% FTSE Shariah0.0% |
| ELEVATEBIO, LLC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| SALUDA MEDICAL INC | UNSCREENED | 0.01% | no in-house ratios for this holding |
| KARDIUM INC/US | UNSCREENED | 0.01% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.01% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.01% | no in-house ratios for this holding |
| MEDICAL MICROINSTRUMENTS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CYCLERION THERAPEUTICS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| TUBULIS GMBH | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 31 points of portfolio weight — 62.7% of it passes AAOIFI, 31.2% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 62.7% ratios fail on 8.9% 30.6% not rated under AAOIFI
ratios pass on 33.2% ratios fail on 35.2% 33.8% not rated under Usmani
ratios pass on 57.4% ratios fail on 11.6% 33.3% not rated under Dow Jones Islamic
ratios pass on 57.4% ratios fail on 10.8% 34.0% not rated under S&P Shariah
ratios pass on 31.2% ratios fail on 37.2% 33.8% not rated under MSCI Islamic
ratios pass on 57.4% ratios fail on 11.1% 33.8% not rated under MSCI Islamic M-Series
ratios pass on 33.7% ratios fail on 34.7% 33.8% not rated under FTSE Shariah
70 of 152 listed holdings carry our own per-methodology verdicts (80% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 61 (67% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 3.49% |
| CVS CVS HEALTH CORP | 1.29% |
| VTRS VIATRIS INC | 1.20% |
| MRNA MODERNA INC | 1.18% |
| RPRX ROYALTY PHARMA PLC | 1.08% |
| PRVA PRIVIA HEALTH GROUP INC | 0.93% |
| ELV ELEVANCE HEALTH INC | 0.75% |
| KYMR KYMERA THERAPEUTICS INC | 0.63% |
| MDLN MEDLINE INC | 0.63% |
| WAY WAYSTAR HOLDING CORP | 0.37% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Select Health Care Portfolio (FHCLX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYELI LILLY and CO | 8.03% | Compliant |
| DHRDANAHER CORP | 6.89% | Compliant |
| JNJJOHNSON and JOHNSON | 4.91% | Compliant |
| TMOTHERMO FISHER SCIENTIFIC INC | 4.33% | Compliant |
| UNHUNITEDHEALTH GROUP INC | 3.49% | Non-compliant |
| ALNYALNYLAM PHARMACEUTICALS INC | 2.40% | Compliant |
| GILDGILEAD SCIENCES INC | 2.21% | Compliant |
| BSXBOSTON SCIENTIFIC CORP | 2.17% | Compliant |
| ASNDASCENDIS PHARMA A/S | 2.17% | Compliant |
| Fidelity Revere Street Trustnot matched to a ticker | 2.17% | Not screened |
Top 10 of 152 holdings, 38.8% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for FHCLX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
Tracked since 2026-09-07.
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.